Pharmacological studies on a new l,5-benzothiazepine derivative (CRD-401).
D000241:Adenosine / Q000494:pharmacology; D000818:Animals; D000840:Anisoles / Q000494:pharmacology; D001552:Benzazepines / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects*; D004285:Dogs; D004347:Drug Interactions; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007408:Intestinal Absorption; D008297:Male; D008744:Methylamines / Q000494:pharmacology; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D012039:Regional Blood Flow / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D013237:Stereoisomerism; D014665:Vasodilator Agents / Q000494:pharmacology*
D000840:Anisoles; D001552:Benzazepines; D008744:Methylamines; D014665:Vasodilator Agents; D000241:Adenosine; D010100:Oxygen